Skip to main content

Table 1 Baseline characteristics.

From: Predictive value of less than moderate residual mitral regurgitation as assessed by transesophageal echocardiography for the short-term outcomes of patients with mitral regurgitation treated with mitral valve repair

Variables Group 1 (n = 54) Group 2 (n = 44) P value
Age, years 62.3 ± 11.5 66.6 ± 10.5 0.11
Women, n (%) 19 (35) 18 (41) 0.56
Weight, kg 73.4 ± 14.7 68.9 ± 13.7 0.13
Height, cm 172.1 ± 9.0 168.9 ± 8.9 0.07
Body mass index, kg/m2 24.9 ± 3.9 24.0 ± 3.4 0.40
Current smoker, n (%) 10 (19) 7 (16) 0.73
Diabetes mellitus, n (%) 15 (28) 11 (25) 0.76
Hyperlipidemia, n (%) 22 (41) 17(39) 0.83
Arterial hypertension, n (%) 22 (41) 24 (55) 0.17
Ejection fraction, % 57.9 ± 9.4 55.3 ± 8.3 0.13
NYHA 3/4, n (%) 30 (56) 31 (70) 0.20
COPD, n (%) 9 (17) 6 (14) 0.68
Other concomitant diseases, n (%) 13 (19) 10 (16) 0.88
  1. NYHA-New York Heart Association (classification). COPD-chronic obstructive pulmonary disease. Group 1-no residual mitral regurgitation. Group 2-less than moderate mitral regurgitation.